Evidence map›Paper›PMID 42791975›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Clinical and Microbiological Characteristics of Early

Begüm Nalça Erdin, İrfan Aydın, Yüksel Akkaya, Meziyet Zeliha Gürlek Ustabaşı, Zeliha Alıcıkuş, Can Turan, İbrahim Halil Kılıç

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Begüm Nalça ErdinDepartment of Microbiology, Health Sciences University Darıca Farabi Training and Research Hospital, 41700 Kocaeli, Türkiye.
İrfan AydınPharmacy Services Program, Pharmacy Services Department, Health Services Vocational School, Fenerbahce University, 34758 Istanbul, Türkiye.ORCID 0000-0001-5488-2262
Yüksel AkkayaDepartment of Microbiology, Health Sciences University Ümraniye Training and Research Hospital, 34764 Istanbul, Türkiye.ORCID 0000-0003-1297-944X
Meziyet Zeliha Gürlek UstabaşıDepartment of Anesthesia and Resuscitation, Health Sciences University Ümraniye Training and Research Hospital, 34764 Istanbul, Türkiye.
Zeliha AlıcıkuşDepartment of Anesthesia and Resuscitation, Health Sciences University Ümraniye Training and Research Hospital, 34764 Istanbul, Türkiye.
Can TuranGeneral Intensive Care Unit, Acıbadem Ataşehir Hospital, 34642 Istanbul, Türkiye.
İbrahim Halil KılıçDepartment of Biology, Faculty of Arts and Sciences, Gaziantep University, 27310 Gaziantep, Türkiye.ORCID 0000-0002-0272-5131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsAdult patients hospitalized between January 2021 and December 2022 with

resultsThirty-three adult patients and 62 clinical isolates were included. The mean age was 67.8 years, and 20 patients (60.6%) were aged 65 years or older. Most patients had prior ICU admission (93.9%), urinary catheterization (97.0%), central venous catheterization (90.9%), mechanical ventilation (81.8%), and broad-spectrum antimicrobial exposure. Blood cultures represented the most frequent source of isolation (56.5%), followed by urine cultures (27.4%). Resistance rates were 98.4% for amphotericin B, 88.7% for fluconazole, 6.6% for micafungin, and 6.5% for caspofungin. Overall mortality was 72.7%. While mortality was numerically higher among patients aged 65 years or older and those requiring inotropic support, only the need for mechanical ventilation was statistically significantly associated with mortality. The cohort-level APACHE II-based expected mortality was 48.0%, whereas observed mortality was 72.7%; this comparison was descriptive and no formal calibration analysis was performed.

conclusionsEarly institutional

Indexed as

antifungal resistanceCandida auriscandidemiaCandidozyma aurisintensive care unitretrospective case seriesTürkiye

Identifiers

PMID42791975
PMCPMC13603228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.